VivoSeq
Psychiatry

Insomnia Disorder

3

Pipeline Programs

2

Active Trials

4

Companies Involved

Insomnia Disorder is an early-stage landscape with 3 programs across 4 companies. The most active players are Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd., Purdue Pharma LP. 3 programs are in Phase 3.

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

11/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

4

clinical trials

Completed2 · 50%
Not yet recruiting1 · 25%
Recruiting1 · 25%

Trial Activity

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)